Sinopharm (company)

Common card · No. 435470

China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group (SEHK: 1099, via a 51–49 joint venture, Sinopharm Industrial Investment, with Fosun Pharmaceutical), China Traditional Chinese Medicine (SEHK: 570, mostly via Sinopharm Group Hongkong Co., Ltd.), Shanghai Shyndec Pharmaceutical (SSE: 600420, via a wholly owned research institute based in Shanghai), and Beijing Tiantan Biological Products (SSE: 600161, via China National Biotec Group). China National Pharmaceutical Group was supervised by the State-owned Assets Supervision and Administration Commission of the State Council. Sinopharm was ranked 109th in the 2021 Fortune Global 500 list.

Read on Wikipedia · Image N509FZ, CC BY-SA 4.0